Britain probing AstraZeneca-Alexion deal over competition concerns
By Lawce in Business
Updated 3 years ago
Britain's competition regulator said on Tuesday it has started a probe into AstraZeneca's (AZN.L) $39 billion takeover of U.S. drugmaker Alexion (ALXN.O) for possibly reducing competition in the UK market or elsewhere. The Competition and Markets Authority said it was inviting comments from any interested party on the deal to...
